CAS: 186593-43-1; 5-Amino-3-Bromo-2-Methylpyridine

该化合物是一种溴化丙烯衍生物,在3点有一个矿物质功能组,在6点有一个甲基替代组,该化合物是有机合成的多用途中间体,特别是在制药,农用化学品和功能材料的制作方面,其溴元素为交叉反应提供了回动性,如Suzuki或Buchwald-Hartwig,而该矿群则能够进一步衍生.甲基替代可增强消毒和电子特性,影响随后反应中的再生选择性.高纯度和定义明确的结构使其适合需要精确分子修改的研究和工业应用.建议由于潜在的敏感性而在惰性条件下进行适当处理.

结构式图片

相似化合物

186593-42-0 914358-73-9 890092-29-2

欧盟法规

ECHA物质C&L通报

上下游产品

3-bromo-2-methyl-5-nitropyridine iron 5-bromo-6-methylnicotinic acid 5-nitro-2-hydroxypyridine 2-(5-bromo-6-methylpyridin-3-yl)isoindoline-1,3-dione (S)-N-((S)-1-(3-bromo-5-(1,3-dioxoisoindolin-2-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-methylpropane-2-sulfinamide (S)-tert-butyl 1-(3-bromo-5-(1,3-dioxoisoindolin-2-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethylcarbamate (S)-tert-butyl 1-(3-(3-carbamoyl-4-fluorophenyl)-5-(1,3-dioxoisoindolin-2-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethylcarbamate

合成工艺路线路线简述

  • 合成目标产物 5-Amino-3-Bromo-2-Methylpyridine 主要起始原料 5-Bromo-6-Methylnicotinicacid
  • (文献来源)合成步骤主要原料 5-Bromo-6-Methylnicotinicacid
2-羟基-5-硝基吡啶置于盐酸,N-溴代丁二酰亚胺(Nbs),铁粉,Sodium Hydride,氯化铵,三溴氧磷体系中,用 四氢呋喃,1,4-二氧六环,甲醇,水,乙腈 用作溶剂,化学反应 2.0H,反应生成5-氨基-3-溴-2-甲基吡啶
参考文献:Compounds For Inflammation And Immune-Related Uses
标题:Compounds For Inflammation And Immune-Related Uses
摘要:该发明涉及某些化合物或其药用可接受的盐,溶剂合物,包合物或前药,这些化合物可用作免疫抑制剂,并用于治疗和预防炎症症状,过敏疾病和免疫紊乱.

海关参考信息

专利信息


专利号:WO-2023086801-A1
优先权日:2021-11-09
标题 :Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
发明人:HOUZE JONATHAN B; PANDYA BHAUMIK; KAPLAN ALAN P; BOS MAXENCE; MANCUSO JOHN; FRANZONI IVAN
权利人:VIGIL NEUROSCIENCE INC
摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 ('TREM2'). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.

专利号:WO-2024159285-A1
优先权日:2023-01-30
标题 :Nav1.7- and/or nav1.8-inhibiting aryl pyridine compounds, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits
发明人:BARREIRO GABRIELA; SANT’ANA DANILO PEREIRA DE; MONTEIRO JÚLIA LAMMOGLIA; GAMBA LUIS EDUARDO REINA; LIMA LÃ?DIA MOREIRA; FRAGA CARLOS ALBERTO MANSSOUR; BARREIRO ELIEZER JESUS DE LACERDA
权利人:EUROFARMA LABORATORIOS S A; UNIV FEDERAL DO RIO DE JANEIRO – UFRJ
摘要:The present invention relates to Nav1.7- and/or Nav1.8-inhibiting aryl pyridine compounds. More specifically, the present invention relates to aryl pyridines comprising formula (I): (I), in which the substituents R1 to R10 are selected independently of the groups defined in the description, as well as to processes for preparing same, compositions comprising at least one of these compounds, uses, treatment methods for treating or preventing pain-related pathologies, and kits. The present invention pertains to the fields of medicinal chemistry and organic synthesis, as well as to the treatment of pain-related diseases.

专利号:WO-2024159288-A1
优先权日:2023-01-30
标 题:Nav1.7- and/or nav1.8-inhibiting amides, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits
发明人:BARREIRO GABRIELA; SANT'ANA DANILO PEREIRA DE; MONTEIRO JÚLIA LAMMOGLIA; GAMBA LUIS EDUARDO REINA; LIMA LÃ?DIA MOREIRA; FRAGA CARLOS ALBERTO MANSSOUR; BARREIRO ELIEZER JESUS DE LACERDA
权利人:EUROFARMA LABORATORIOS S A; UNIV FEDERAL DO RIO DE JANEIRO – UFRJ
摘要:The present invention relates to Nav1.7- and/or Nav1.8-inhibiting amides. More specifically, the present invention relates to amides comprising formula (I): (Ia) (Ib), in which the substituents R1 to R27 are selected independently of the groups defined in the description, as well as to processes for the preparation thereof, compositions comprising at least one of said compounds, uses, treatment methods for treating or preventing pain-related pathologies, and kits. The present invention pertains to the fields of medicinal chemistry and organic synthesis, as well as to the treatment of pain-related disorders.
济南贝莱尔化学科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.blechem.com
企业联系电话:0531-88950629,15969711936👤
📞济南贝莱尔化学科技有限公司 ⚠️参考联系方式
联系人:陶经理
电话:0531-88950629,15969711936
手机:15969711936
传真:0531-88950629
邮箱:taozz98@126.com
通信地址: 济南市天桥区桑梓店济南新材料交易中心
邮编: 250000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:济南市天桥区桑梓店济南新材料交易中心
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献

参考DOI号:10.1021/jacs.6b03930
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知